Shaping Heterogeneity of Naive CD8<sup>+</sup> T Cell Pools-Reference-Cited by-同舟云学术

Shaping Heterogeneity of Naive CD8⁺ T Cell Pools

Published:2023 Issue:1 Volume:23 Page:
ISSN:1598-2629
Container-title:Immune Network
language:en
Short-container-title:Immune Netw

Author:

Lee Sung-Woo¹²^ORCID,Lee Gil-Woo¹²^ORCID,Kim Hee-Ok³^ORCID,Cho Jae-Ho¹²⁴^ORCID

Affiliation:

1. Medical Research Center for Combinatorial Tumor Immunotherapy, Department of Microbiology and Immunology, Chonnam National University Medical School, Hwasun 58128, Korea.

2. Immunotherapy Innovation Center, Chonnam National University Medical School, Hwasun 58128, Korea.

3. Selecxine Inc., Seoul 05855, Korea.

4. BioMedical Sciences Graduate Program, Chonnam National University Medical School, Hwasun 58128, Korea.

Funder

National Research Foundation of Korea

Chonnam National University Hwasun Hospital

Chonnam National University

Publisher

XMLink

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

https://immunenetwork.org/pdf/10.4110/in.2023.23.e2

Reference100 articles.

1. Heterogeneity and Cell-Fate Decisions in Effector and Memory CD8+ T Cell Differentiation during Viral Infection

2. Molecular regulation of effector and memory T cell differentiation

3. Transcriptional and Epigenetic Regulation of Effector and Memory CD8 T Cell Differentiation

4. Epigenetic control of CD8+ T cell differentiation

5. RNA Metabolism in T Lymphocytes

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DEPDC5 protects CD8+ T cells from ferroptosis by limiting mTORC1-mediated purine catabolism;Cell Discovery;2024-05-20

2. Developmental self-reactivity determines pathogenic Tc17 differentiation potential of naive CD8+ T cells in murine models of inflammation;Nature Communications;2024-04-04

3. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis;International Journal of Molecular Sciences;2024-02-21

4. Optimising IL-2 for Cancer Immunotherapy;Immune Network;2024

5. CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential;Experimental & Molecular Medicine;2023-11-01